MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$759M
Cash and cash
equivalents
$222M
Prepaid expenses and
other current assets
$15M
Receivable from
collaboration partners ( and 6...
$11M
Total current assets
$1,007M
Other noncurrent
assets
$63M
Property and equipment,
net
$40M
Long-term marketable
securities
$29M
Total assets
$1,139M
Total liabilities and
stockholders equity
$1,139M
Total stockholders
equity
$631M
Total current
liabilities
$231M
Other noncurrent
liabilities
$135M
Long-term debt
$99M
Deferred revenue,
noncurrent (43 and 234 to a...
$43M
Accumulated deficit
-$1,485M
Common stock and
additional paid-in capital...
$2,116M
Other current
liabilities
$154M
Accounts payable (24 and
to a related party)
$42M
Deferred revenue (35 and
85 to a related...
$35M
Back
Back
Balance Sheet
source: myfinsight.com
Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences, Inc. (RCUS)